DrugPatentWatch Report Store
Showing 637–648 of 905 results
- Drug Patent Reports
RYBELSUS (semaglutide) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
RYDAPT (midostaurin) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
RYTARY (carbidopa; levodopa) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Excipient Business Development Opportunity Reports
SACCHARIN SODIUM Drug Excipient Business Development Opportunity Report, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
SAFYRAL (drospirenone; ethinyl estradiol; levomefolate calcium) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
SALONPAS (menthol; methyl salicylate) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
SANCUSO (granisetron) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
SAVAYSA (edoxaban tosylate) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
SAXAGLIPTIN (saxagliptin hydrochloride) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
SAXENDA (liraglutide recombinant) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
SCEMBLIX (asciminib hydrochloride) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
SCENESSE (afamelanotide) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now
